Some of the world's leading scientists could be working alongside your development team
How collaborating can help you
A typical collaboration could range from a one-off experiment to a two or three year funded lab position or studentship. By working with Medical Research Council scientists you could gain access to some of the finest minds in their fields.
Our track record
One of the most successful industry academic collaborations has been the Division of Signal Transduction Therapy, based at the MRC Protein Phosphorylation Unit and the University of Dundee. Started in July 1998 with 5 years of support. DSTT was renewed for a further 5 years in 2003, and renewed again in 2008 with core funding of £10.8 million over 4 years. Companies involved in the latest renewal are Pfizer, GSK, Boehringer Ingelheim, AstraZeneca and Merck Serono.
Find out more
If you are interested in discussing starting a collaboration with us, please Contact Us.
News feed
MRCT are collaborating with the University of Bristol to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.
MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen work together on project to develop therapeutic against a novel cancer target, soluble CTLA-4.
Aptuscan, a spin out company based on research carried out at the MRC Cancer Cell Unit, has been acquired by Avacta, an AIM-listed biotechnology company.
MRC Technology announced today that they have entered into an agreement with the Association for International Cancer Research (AICR) to assist in the oversight and management of intellectual property (IP) arising from AICR-funded projects.